Literature DB >> 4150834

Effect of chlorpromazine and some of its metabolites on the dopamine-sensitive adenylate cyclase of rat brain striatum.

R J Miller, L L Iversen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4150834     DOI: 10.1111/j.2042-7158.1974.tb09243.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  7 in total

1.  Plasma level studies in psychotropic evaluation.

Authors:  S H Curry
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

2.  The biochemical evaluation of psychotropic drugs.

Authors:  A V Mackay
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

3.  Increased platelet aggregation in patients receiving chlorpromazine: responses to 5-hydroxytryptamine, dopamine and N-dimethyl dopamine.

Authors:  D J Boullin; R P Grimes
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

4.  Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites.

Authors:  D J Boullin; D G Grahame-Smith; R P Grimes; H F Woods
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

5.  A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF.

Authors:  G Alfredsson; B Wode-Helgodt; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

6.  Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.

Authors:  B Wode-Helgodt; G Alfredsson
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Effects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema Factor.

Authors:  Carolin Lübker; Roland Seifert
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.